Cleared Traditional

K120161 - ALPHAPOINT IMAGING SOFTWARE

K120161 is an FDA 510(k) clearance for ALPHAPOINT IMAGING SOFTWARE, manufactured by Radlogics, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K120161 · Radlogics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2012
Decision
85d
Days
Class 2
Risk

K120161 is an FDA 510(k) clearance for the ALPHAPOINT IMAGING SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Radlogics, Inc. (Los Gatos, US). The FDA issued a Cleared decision on April 13, 2012 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Radlogics, Inc. devices

FDA 510(k) Submission Details - K120161

510(k) Number K120161 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2012
Decision Date April 13, 2012
Days to Decision 85 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 107d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1764
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K120161.
INSTAPACS/INSTARISPACS
K120718 · Meddiff Technologies Pvt. , Ltd. · Apr 2012
3MENSIO WORKSTATION
K120367 · Pie Medical Imaging BV · Apr 2012
2D CARDIAC PERFORMANCE ANALYSIS MR 1.0
K120135 · Tomtec Imaging Systems GmbH · Apr 2012
SYNGO.MR SPECTRO ENGINE, SYNGO.MR SPECTRO SVS, SYNGO.MR SPECTRO CSI, SYNGO.MR SPECTRO EXTENSION
K120315 · Siemens Medical Solutions USA, Inc. · Apr 2012
MULTI-MODALITY IMAGE FUSION
K120187 · Igt, LLC Dba Eigen · Apr 2012
SYNAPSE 3D BASE TOOLS
K120361 · Fujifilm Medical Systems U.S.A, Inc. · Apr 2012